India Insulin Market Review to 2018
Intensifying Strategic Alliances Between Companies
September 2014
78
About the Report
About the Report
- The market size of India insulin market in terms of revenue
- Market segmentation by insulin replacement therapy and types of insulin
- Government regulation and support schemes for the Indian insulin market
- Pricing scenario of different insulin brands in India
- Trends and developments in India insulin market
- Growth drivers and challenges in India insulin market
- Market share of major players in the insulin market in India
- Market share and Revenue of major brands by types of insulin
- Company profiles of major players in the Indian insulin market
- Future outlook and projections of the insulin market in India
- Macroeconomic factors affecting the insulin market in India
Products
Products
Insulin, Human Insulin, Analog Insulin, Premix, Rapid Acting, Long Acting, diabetes, Market Size, Market Share, Price of Insulin, diabetic population
Companies
Novo Nordisk India Private Limited, Eli Lilly and Company India Private Limited, Sanofi India Limited, Biocon Limited, Wockhardt Limited
Table of Contents
Table of Contents
1. Asia Pacific Insulin Market Introduction
1.1. Asia Pacific Insulin Market Value Chain
1.2. Asia Pacific Insulin Market Size by Value, 2008-2013
1.3. Asia Pacific Insulin Market Segmentation, 2008-2013
1.3.1. By Geography, 2008-2013
1.3.2. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), 2013
1.3.3. By Types of Insulin (Premix, Rapid Acting, Long Acting), 2013
1.4. New Product Development By Major Insulin Companies
1.5. Trends and Developments in Asia Pacific Insulin Market
Monopoly of Foreign Brands
Phasing Out of Human Insulin
1.6. Growth Drivers and Challenges in Asia Pacific Insulin Market
Shift from Human Insulin to Analog Insulin
Rising Prevalence of Diabetes
Increasing Diabetes Care Expenditure
Low Affordability
Lack of Awareness
1.7. SWOT Analysis of Asia Insulin Market
1.8. Asia Pacific Insulin Market Future Outlook and Projections, 2014-2018
1.8.1. By Geography, 2014-2018
2. India Insulin Market Introduction
3. India Insulin Market Size, FY"2008-FY"2013
4. India Insulin Market Segmentation, FY"2008-FY"2013
4.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin), FY"2008-FY"2013
4.2. By Types of Insulin (Premix, Rapid Acting, long Acting), FY"2008-FY"2013
4.3. Usage by Type of Diabetes, FY"2008-FY"2013
5. Government Regulations and Support Schemes in India Insulin Market
5.1. National Pharmaceutical Pricing Authority (NPPA)
Implications of Pricing Limits by NPPA
5.2. National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)
6. Pricing Scenario in India Insulin Market
7. Trends and Developments in India Insulin Market
Price Gap Between Foreign and Domestic Insulin Brands
Shift of Diabetes to Young Age Group
Strategic Alliances in India Insulin Market
8. Growth Drivers and Challenges in India Insulin Market
Increasing Diabetic Population
Increasing Expenditure on Diabetes Care
Exchange Rate Fluctuation
9. Market Share of Major Companies in India Insulin Market, FY"2013
9.1. By Type of Insulin, FY"2013
9.1.1. By Premix Insulin, FY"2013
9.1.2. By Long Acting Insulin, FY"2013
9.1.3. By Rapid Acting Insulin, FY"2013
10. Company Profiles of Major Players in India Insulin Market
10.1. Novo Nordisk India Pvt. Ltd
10.1.1. Company Overview
10.1.2. Business Strategies
Market Expansion Through Spreading Awareness
Strengthening Research and Development (R&D) Activities
10.1.3. Competitive Standing
10.2. Eli Lilly and Company India Pvt. Ltd.
10.2.1. Company Overview
10.2.2. Business Strategies
Focus on Increasing R&D Investment in India
Concentration Towards the Diabetes Care Segment
10.2.3. Competitive Standing
10.3. Sanofi India Ltd.
10.3.1. Company Overview
10.3.2. Business Strategies
Commence Insulin Production in India
Product Innovation
Patient Awareness Programs
10.3.3. Competitive Standing
10.4. Biocon Ltd.
10.4.1. Company Overview
10.4.2. Competitive Standing
10.5. Wockhardt Ltd.
10.5.1. Company Overview
10.5.2. Competitive Standing
11. India Insulin Market Future Outlook and Projections, 2014-2018
11.1. By Insulin Replacement Therapy (Human Insulin and Analog Insulin, FY"2014-FY"2018
11.2. Cause and Effect Relationship Between Dependable and Independent Variable Factors prevailing in India Insulin Market
12. Macroeconomic Factors in India Insulin Market, 2008-2018
12.1. Diabetic Population in India, 2008-2018
12.2. India Government Spending on Healthcare, FY"2008-FY"2018
12.3. India Consumer Spending on Healthcare, FY"2008-FY"2018
12.4. India Personal Disposable Income, FY"2008-FY"2018
13. Appendix
13.1. Market Definitions
13.2. Abbreviations
13.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
13.4. Disclaimer
List of Figure
Figure 1: Asia Pacific Insulin Market CAGR Growth of Major Asia Pacific Countries in Percentage, 2008-2013
Figure 2: Insulin Market Value Chain
Figure 3: Asia Pacific Insulin Market Size on the Basis of Revenue in USD Million, 2008-2013
Figure 4: Asia Pacific Insulin Market Segmentation on the Basis of Revenue Contribution by Different Geographies in Percentage (%), 2008-2013
Figure 5: Asia Pacific Insulin Market Segmentation by Insulin Replacement Therapy (Human Insulin and Analog Insulin) on the Basis of Revenue Contribution in Percentage (%), 2013
Figure 6: Asia Pacific Insulin Market Segmentation by Types of Insulin (Premix, Rapid Acting and Long Acting) on the Basis of Revenue Contribution in Percentage (%), 2013
Figure 7: Asia Pacific Insulin Market Future Projections on the Basis of Revenue in USD Million, 2014-2018
Figure 8: Asia Pacific Insulin Market Future Projection by Geography on the Basis of Revenue Contribution in Percentage (%), 2014-2018
Figure 9: India Insulin Market Size on the Basis of Revenue in USD Million, FY"2008-FY"2013
Figure 10: India Insulin Market Segmentation by Insulin Replacement Therapy (Human Insulin and Analog Insulin) on the Basis of Revenue Contribution in Percentage (%), FY"2008-FY"2013
Figure 11: India Insulin Market Segmentation by Type of Insulin (Premix, Long Acting and Rapid Acting) on the Basis of Revenue Contribution in Percentage (%), FY"2008-FY"2013
Figure 12: India Insulin Market Segmentation by Type 1 and Type 2 Diabetes on the Basis of Revenue Contribution in Percentage (%), FY"2013
Figure 13: Market Share of Major Companies in India Insulin Market on the Basis of Revenue Contribution in Percentage (%), FY"2013
Figure 14: Market Share of Major Companies in Premix Insulin on the Basis of Revenue Contribution in Percentage (%), FY"2013
Figure 15: Market Share of Major Companies in Long Acting Insulin on the Basis of Revenue Contribution in Percentage (%), FY"2013
Figure 16: Market Share of Major Companies in Rapid Acting Insulin on the Basis of Revenue Contribution in Percentage (%), FY"2013
Figure 17: India Insulin Market Future Projection on the Basis of Revenue in USD Million, FY"2014-FY"2018
Figure 18: India Insulin Market Future Projections on the Basis of Revenue Contribution by Insulin Replacement Therapy in Percentage (%), FY"2014-FY"2018
Figure 19: India Diabetic Population in Million, 2008-2018
Figure 20: India Government Spending on Healthcare in USD Million, FY"2008-FY"2018
Figure 21: India Consumer Spending on Healthcare in USD Million, FY"2008-FY"2018
Figure 22: India Personal Disposable Income in USD Million, FY"2008-FY"2018
List of Table
Table 1: Top 10 Countries with the Largest Diabetic Population Globally, 2013
Table 2: Asia Pacific Insulin Market Segmentation on the Basis of Revenue of Different Geographies in USD Million, 2008-2013
Table 3: Asia Pacific Insulin Market Segmentation by Insulin Replacement Therapy (Human Insulin and Analog Insulin) on the Basis of Revenue in USD Million, 2013
Table 4: Asia Insulin Market Segmentation by Types of Insulin (Premix, Rapid Acting and Long Acting) on the Basis of Revenue in USD Million, 2013
Table 5: New Insulin Development by Major Insulin Companies
Table 6: Mean Diabetes Related Expenditure Per Person with Diabetes in USD, 2012-2013
Table 7: SWOT Analysis of Asia Insulin Market
Table 8: Asia Pacific Insulin Market Future Projection by Geography on the Basis of Revenue in USD Million, 2014-2018
Table 9: India Insulin Market Segmentation by Insulin Replacement Therapy (Human Insulin and Analog Insulin) on the Basis of Revenue in USD Million, FY"2008-FY"2013
Table 10: India Insulin Market Segmentation by Type of Insulin (Premix, Long Acting and Rapid Acting) on the Basis of Revenue in USD Million, FY"2008-FY"2013
Table 11: India Insulin Market Segmentation by Type 1 and Type 2 Diabetes on the Basis of Revenue in USD Million, FY"2013
Table 12: Price Ceiling for Domestically Manufactured Insulin
Table 13: Price Ceiling for Imported Insulin
Table 14: Prices of Various Insulin Brands in India
Table 15: Revenue Contribution of Major Companies in India Insulin Market in USD Million, FY"2013
Table 16: Revenue of Major Companies in India Premix Insulin Market by Brands in USD Million, FY"2013
Table 17: Revenue of Major Companies in India Long Acting Insulin Market by Brands in USD Million, FY"2013
Table 18: Revenue of Major Companies in India Rapid Acting Insulin Market by Brands in USD Million, FY"2013
Table 19: India Insulin Market Future Projections on the Basis of Revenue by Insulin Replacement Therapy in USD Million, FY"2014-FY"2018
Table 20: Cause and Effect Relationship between the Dependent and Independent Variables Prevailing in India Insulin Market
Table 21: Correlation Matrix of India Insulin Market
Table 22: Regression Coefficients Output
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.